A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

“The study looks at an important area of colorectal cancer biology using rigorous mouse models. And it's attempting to address two pathways by which colon cancer initiates,” said Nilay Sethi, a cancer ...

For example, the National Institutes of Health (NIH) explains that "dietary emulsifiers promoted colon cancer in a mouse model by altering gut microbes and increasing gut inflammation." And as the New ...

image: Epigenetic research reveals a potential new treatment for colorectal cancer and other solid tumors. view more Credit: Elizabeth Cook FOR IMMEDIATE RELEASE A little-known mouse protein ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its ...

Fiber digestion produces short-chain fatty acids like propionate and butyrate, which directly alter gene expression with anti ...

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...

In their study, published in the Proceedings of the National Academy of Sciences, the group found that mice with Alzheimer's-like symptoms were less likely than control colorectal mouse models to ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has today announced additional in vivo validation for its first-in-class approach against cancer as the Company continues to apply its ...

Colorectal cancer (CRC ... Here the authors model the CRC subtypes with genetically engineered mouse organoids, identify the metabolic signature of CMS3 is driven by enterocyte-like ...